7-(2,2-dimethylpropyl)-6-[(5-methoxy-2-oxospiro[indole-3,4'-piperidin]-1(2H)-yl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile

ID: ALA452826

PubChem CID: 10004326

Max Phase: Preclinical

Molecular Formula: C26H30N6O2

Molecular Weight: 458.57

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1)C1(CCNCC1)C(=O)N2Cc1cc2cnc(C#N)nc2n1CC(C)(C)C

Standard InChI:  InChI=1S/C26H30N6O2/c1-25(2,3)16-32-18(11-17-14-29-22(13-27)30-23(17)32)15-31-21-6-5-19(34-4)12-20(21)26(24(31)33)7-9-28-10-8-26/h5-6,11-12,14,28H,7-10,15-16H2,1-4H3

Standard InChI Key:  KNNCFAJHGHOEJI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   11.2924   -4.0204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2883   -4.8459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0723   -5.1038    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8737   -3.1944    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8737   -4.0200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5868   -4.4307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2957   -3.1944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5868   -2.7796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6213   -5.3295    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.3264   -5.8905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1331   -6.0695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4664   -6.8210    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.7492   -5.5141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4627   -5.9283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2861   -6.7309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8927   -7.2853    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.6762   -7.0383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8496   -6.2318    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2417   -5.6809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2878   -7.5952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8932   -8.1465    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.0560   -7.5325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4669   -8.2479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8771   -8.9610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1831   -7.8383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7530   -8.6655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0791   -3.7706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5599   -4.4434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3795   -4.3641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7193   -3.6127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2376   -2.9397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4197   -3.0222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5746   -2.1864    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.3960   -2.1037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  6  1  0
 15 16  1  0
  6  1  1  0
 16 17  2  0
  1  7  1  0
 17 18  1  0
  7  8  1  0
 18 19  2  0
 19 14  1  0
  4  5  1  0
 17 20  1  0
  2  9  2  0
 20 21  3  0
  1  2  1  0
 12 22  1  0
  3 10  1  0
 22 23  1  0
 23 24  1  0
 10 11  1  0
 23 25  1  0
 11 12  1  0
 23 26  1  0
  2  3  1  0
  3 28  1  0
 27 28  2  0
 12 15  1  0
 28 29  1  0
 14 13  1  0
 29 30  2  0
 13 11  2  0
 30 31  1  0
 27  1  1  0
 31 32  2  0
 32 27  1  0
  4  8  1  0
 31 33  1  0
 14 15  2  0
 33 34  1  0
M  END

Associated Targets(Human)

CTSK Tchem Cathepsin K (3011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSL Tclin Cathepsin L (3852 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ctsk Cathepsin K (62 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Serum (604 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 458.57Molecular Weight (Monoisotopic): 458.2430AlogP: 3.53#Rotatable Bonds: 4
Polar Surface Area: 96.07Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.78CX LogP: 3.33CX LogD: 0.99
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.64Np Likeness Score: -0.51

References

1. Teno N, Masuya K, Ehara T, Kosaka T, Miyake T, Irie O, Hitomi Y, Matsuura N, Umemura I, Iwasaki G, Fukaya H, Toriyama K, Uchiyama N, Nonomura K, Sugiyama I, Kometani M..  (2008)  Effect of cathepsin K inhibitors on bone resorption.,  51  (17): [PMID:18707091] [10.1021/jm800626a]

Source